NorthWest Biotherapeutics Inc (NWBO)

[doingmybest]

If it is true that 13 cancers will be studied, and, if the trial has a PD1 arm I think FDA will need to and will want to be intricately involved and there will an SPA. This will be potentially a scientific breakthrough of enormous proportions and the last thing the agency would want is to have it get stuck in a gray zone for an extended length of time due to a lack of clarity of any data, of any endpoints, or, of anything. I do think there will be a PD1 arm, it has become too obviously necessary. Just thinking of what this could mean to medical science for cancer patients is enough to shake anyone. I was hoping Q1 would have cleared the air with DCVax-L, but, now I am hopeful Q2 will clear all the air here including L, Direct, investigation and future financing, though I think the first two will dwarf the next two in impact.